Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period from November 1, 2017, to April 30, 2018. The report serves as a Block Listing Six Monthly Return detailing the status of various employee share schemes and deferred bonus plans. It does not contain general business operations or financial performance data.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the movement of securities within specific employee compensation schemes.
Material Changes in Share Schemes
The following changes occurred in unallotted securities balances during the reporting period:
- 2009 Deferred Annual Bonus Plan: Issued 165,219 securities; ending balance is 33,863.
- Share Option Plan - Ordinary Shares: Issued 865,821 securities; ending balance is 2,693,951.
- Share Option Plan - ADS: Issued 275,126 securities; ending balance is 7,909,994.
- Share Save Plan 2012: Issued 714,764 securities; ending balance is 827,306.
No increases were applied to the block schemes during this period.
Outlook, Risks, and Unusual Items
The filing notes that six legacy employee share schemes have expired and will no longer be included in future Block Listing Six Monthly Returns. These include the Glaxo Wellcome UK and International Share Option Schemes, the Glaxo Wellcome 1999 Share Option Plan, and three variants of the SmithKline Beecham 1989 Executive Share Option Plan. No other risks, contingencies, or management commentary regarding future outlook are provided in this text.
Investor Verification Checklist
- Verify the total number of shares issued under the Share Option Plan - Ordinary Shares (865,821) against internal cap tables.
- Confirm the remaining balance of the 2009 Deferred Annual Bonus Plan (33,863) to assess near-term dilution potential.
- Ensure the expired schemes listed are correctly removed from future tracking and reporting.
- Note that this filing contains no financial performance data; refer to Form 20-F or quarterly reports for revenue and earnings.